11-64809879-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001370259.2(MEN1):c.231C>G(p.Tyr77*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001370259.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEN1 | NM_001370259.2 | c.231C>G | p.Tyr77* | stop_gained | Exon 2 of 10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia, type 1 Pathogenic:3
- -
This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MEN1 are known to be pathogenic (PMID: 12112656, 17853334). This variant has been reported in an individual or family undergoing MEN1 genetic testing (PMID: 15714081). ClinVar contains an entry for this variant (Variation ID: 527270). This sequence change creates a premature translational stop signal (p.Tyr77*) in the MEN1 gene. It is expected to result in an absent or disrupted protein product. -
Variant summary: MEN1 c.231C>G (p.Tyr77X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (example: c.228delC [p.Tyr77ThrfsX42], c.292C>T [p.Arg98X]). The variant was absent in 223538 control chromosomes. c.231C>G has been reported in the literature in individuals affected with Multiple Endocrine Neoplasia Type 1 (example: Kovesdi_2019, Isailovic_2019, Klein_2005). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submitter has assessed the variant since 2014: the variant was classified as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Observed in an individual undergoing testing for Multiple Endocrine Neoplasia type 1 (Klein 2005); This variant is associated with the following publications: (PMID: 25525159, 15714081) -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Y77* pathogenic mutation (also known as c.231C>G), located in coding exon 1 of the MEN1 gene, results from a C to G substitution at nucleotide position 231. This changes the amino acid from a tyrosine to a stop codon within coding exon 1. This mutation has been previously reported in individuals with multiple endocrine neoplasia type 1 (MEN1) (Klein RD et al. Genet. Med., 2005 Feb;7:131-8; Isailovic T et al. J Med Biochem, 2019 Mar;38:38-44). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at